Penthrox is approved in Thailand
28 April 2020
ASX Announcement
Penthrox is approved in Thailand
Medical Developments International Limited (ASX: MVP), announce today that Penthrox® has been granted Market Authorisation in the Kingdom of Thailand. The Marketing Authorisation issued by the Thailand Food and Drug Administration (TFDA), is for Penthrox® to be used for Emergency relief of moderate to severe pain in conscious adult patients with trauma and associated pain.
Chairman David Williams said: “This is an important approval as Thailand is a key market for Penthrox throughout the Asian Region. It is the first approval we have obtained with our partners Daiichi Sankyo who are also our partners in China and Vietnam. We expect the granting of this Marketing Authorisation will have positive ramifications for the rest of this region and we hope this approval is a catalyst for a number of other country approvals in Asia.”